• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SMITH & NEPHEW ORTHOPAEDICS LTD BHR RESURFACING FEMORAL HEAD 48MM; PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/METAL, RESURFACING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SMITH & NEPHEW ORTHOPAEDICS LTD BHR RESURFACING FEMORAL HEAD 48MM; PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/METAL, RESURFACING Back to Search Results
Model Number 74123148
Medical Device Problem Code Biocompatibility (2886)
Health Effect - Clinical Codes Infiltration into Tissue (1931); Pain (1994); Synovitis (2094); Ambulation or Postural Difficulties (2544); Metal Related Pathology (4530)
Date of Event 08/02/2021
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that, after right bhr surgery was performed on (b)(6) 2020 due to osteoarthritis, long-standing right hip, and groin pain, the patient experienced pain and progressive limp.An mri identified presence of adverse local tissue reaction and elevation in cobalt and chromium levels.This adverse event was treated with a revision surgery on (b)(6) 2021, in which severe synovitis and dehiscence of the anterolateral capsular was observed.Repair to the trochanter was required.Patient's current health status is unknown.
 
Additional Manufacturer Narrative
Internal complaint reference number: (b)(4).
 
Additional Manufacturer Narrative
H3, h6.It was reported that right hip revision surgery was performed.As of today, the implanted devices, all of which were used in treatment have not been returned for evaluation.A review of the historical complaints data for the acetabular cup and the femoral head was performed using batch numbers to evaluate patterns of repeated failures or defects over the lifetime of the product and using part numbers and the reported failure modes to evaluate patterns of repeated failures or defects in a timeframe prior 12 months as of the complaint aware date.No other complaints were identified to involve this batches.Other similar complaints were identified for the part numbers and the reported/related failure modes.This will continue to be monitored.In the absence of the actual devices, the production records were reviewed for the devices reportedly involved in this incident.All released devices involved met manufacturing specifications upon release for distribution review of the product ifu found adequate warnings and precautions in relation to the alleged failure modes.A risk management review was performed.The alleged failure modes and associated risks have been anticipated within the risk file and the anticipated risk level is still adequate.No further actions are required at this time.A review of historic escalation actions related to the products and similar complaint events was performed.Following the review, no prior applicable escalation actions were identified.The available medical documents were reviewed.The revision operative note did not note any findings adverse local tissue reaction.Per the surgical technique, the acetabular component is to be impacted with 15-20 degrees of anteversion and 40-45 degrees abduction.However, the surgeon noted intraoperatively that the acetabular component was ¿in basically neutral version¿.It is unknown if this position of the acetabular component was a migration since implantation and if it led to accelerated wear and the reported elevation in cobalt and chromium levels, along with the intraoperative findings of synovitis and dehiscence of the anterolateral abductors trochanter.Although it was reported the patient had elevated cobalt and chromium levels, neither the levels nor the lab reports were provided for review.Without the supporting lab/pathology results, imaging, and/or the analysis of the explanted components, the root cause of the reported clinical reactions cannot be confirmed.It cannot be concluded that the reported clinical reactions were associated with a mal-performance of the implant or implant failure.The patient impact beyond cannot be determined.Without the return of the devices used in treatment or additional information we cannot advance the investigation or confirm this complaint; our investigation remains inconclusive, and a definitive root cause cannot be determined.Specific factors known to contribute to the alleged fault are excessive physical activity levels, unreasonable stress on replacement system, excessive patient weight, trauma to the joint replacement, loosening of components may increase production of wear particles and accelerate damage to the bone.Should the devices or additional information be received, the complaint will be reopened.Based on this investigation, the need for corrective and preventative actions is not indicated.H11: corrected information in h6 (health effect - clinical code).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BHR RESURFACING FEMORAL HEAD 48MM
Common Device Name
PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/METAL, RESURFACING
Manufacturer (Section D)
SMITH & NEPHEW ORTHOPAEDICS LTD
aurora house, spa park
leamington spa warwickshire CV31 3HL
UK  CV31 3HL
Manufacturer (Section G)
SMITH & NEPHEW ORTHOPAEDICS LTD
aurora house, spa park
leamington spa warwickshire CV31 3HL
UK   CV31 3HL
Manufacturer Contact
holly topping
7000 west william cannon drive
austin, TX 78735
5123913905
MDR Report Key14435778
Report Number3005975929-2022-00271
Device Sequence Number17551447
Product Code NXT
UDI-Device Identifier03596010552426
UDI-Public03596010552426
Combination Product (Y/N)N
Initial Reporter StateMD
Initial Reporter CountryUS
PMA/510(K) Number
P040033
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2020
Device Explanted Year2021
Reporter Type Manufacturer
Report Source Consumer
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 08/25/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Lay User/Patient
Device Expiration Date06/11/2025
Device Model Number74123148
Device Catalogue Number74123148
Device Lot Number20FW00013
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 04/25/2022
Supplement Date Received by Manufacturer08/25/2022
Initial Report FDA Received Date05/19/2022
Supplement Report FDA Received Date08/25/2022
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured06/11/2020
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
ACETABULAR CUP HAP SIZE 48/54
Outcome Attributed to Adverse Event Hospitalization; Required Intervention;
Patient SexMale
-
-